Drugs for Hypertensive Heart Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 44)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Irbesartan |
Approved, Investigational |
Phase 4 |
|
138402-11-6 |
3749 |
Synonyms:
2-Butyl-3-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1,3-diazaspiro[4.4]non-1-en-4-one
2-N-Butyl-3-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1,3-diazaspiro(4,4)non-1-en-4-one
Aprovel
Aprovel®|Avapro®|Karvea®|SR 47436
Avalide
Avapro
BMS 186295
BMS-186295
|
IFIRMASTA
Irbesarran
IRBESARTAN
Irbesartan [Usan:Inn]
Karvea
Lrbesartan
SABERVEL
SR-47436
|
|
2 |
|
Ramipril |
Approved |
Phase 4 |
|
87333-19-5 |
5362129 |
Synonyms:
(2S-(1(R*(r*)),2a,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylate
(2S-(1(R*(r*)),2a,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid
(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylate
(2S-(1(R*(r*)),2alpha,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid
(2S-(1(R*(r*)),2α,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylate
(2S-(1(R*(r*)),2α,3abeta,6abeta))-1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid
Acovil
Almirall brand OF ramipril
Altace
ALTACE (TN)
Altace®|HOE-498|Tritace®
Astra brand OF ramipril
AstraZeneca brand OF ramipril
Aventis brand OF ramipril
Aventis pharma brand OF ramipril
C09AA05
Carasel
Cardace
Delix
HOE 498
HOE-498
|
Hoechst brand OF ramipril
Hypren
Hytren
LOPACE
Lostapres
Monarch brand OF ramipril
Pramace
Promed brand OF ramipril
Quark
Ramace
RAMICOR
RAMIPRIL
Ramiprilum
Ramiprilum [Latin]
RANACE
Triatec
Tritace
Unipril
Vesdil
Zabien
|
|
3 |
|
Angiotensin-Converting Enzyme Inhibitors |
|
Phase 4 |
|
|
|
4 |
|
HIV Protease Inhibitors |
|
Phase 4 |
|
|
|
5 |
|
protease inhibitors |
|
Phase 4 |
|
|
|
Synonyms:
|
6 |
|
Spironolactone |
Approved |
Phase 3 |
|
1952-01-7, 52-01-7 |
5833 |
Synonyms:
ABBOLACTONE
Acelat
Aldace
Aldactazide
Aldactide
Aldactone
Aldactone a
Aldactone®|spiractin|spirotone
Alderon
Aldopur
Almatol
Alphapharm brand OF spironolactone
Alpharma brand OF spironolactone
Alter brand OF spironolactone
Altex
Aquareduct
Ashbourne brand OF spironolactone
Azupharma brand OF spironolactone
Betapharm brand OF spironolactone
Cardel brand OF spironolactone
CAROSPIR
CT Arzneimittel brand OF spironolactone
CT, Spiro von
CT-Arzneimittel brand OF spironolactone
Deverol
Dexo brand OF spironolactone
DIATENSEC
Dira
Duraspiron
Espironolactona
Espironolactona [INN-Spanish]
Espironolactona alter
Espironolactona mundogen
Euteberol
Flumach
Frumikal
Generosan brand OF spironolactone
GX SPIRONOL
Hormosan brand OF spironolactone
Jenapharm brand OF spironolactone
Jenaspiron
Lacalmin
Lacdene
LARACTONE
Mayoly-spindler brand OF spironolactone
Melarcon
Merck dura brand OF spironolactone
Mundogen brand OF spironolactone
Nefurofan
Novo spiroton
Novopharm brand OF spironolactone
Novo-spiroton
NovoSpiroton
NSC-150399
Osyrol
Pfizer brand OF spironolactone
|
Pharmafrid brand OF spironolactone
Practon
Roche brand OF spironolactone
Sagisal
SC-9420
Searle brand OF spironolactone
Sincomen
SNL
Spiractin
Spiresis
SPIRETIC
Spiridon
SPIRNOLACTONE
Spiro l.u.t.
Spiro von CT
Spirobeta
Spiroctan
SPIROCTAN 100
SPIROCTAN 25
SPIROCTAN 50
Spiroctanie
Spiroderm
Spirogamma
Spirolactone
Spirolakton
Spirolang
Spirolone
Spirone
Spirono isis
Spironocompren
Spirono-isis
SPIRONOLACTONE
Spironolactone [BAN:INN:JAN]
Spironolactone A
Spironolactonum
Spironolactonum [INN-Latin]
Spironolattone
Spironolattone [DCIT]
Spironone
Spirospare
SPIROSPARE 100
SPIROSPARE 25
Spiro-Tablinen
SPIROTONE
Sprioderm
Supra-puren
Suracton
Uractone
Urusonin
Veroshpiron
Verospiron
Verospirone
Verospirone Opianin
Von CT, spiro
Wörwag brand OF spironolactone
Xenalon
|
|
7 |
|
diuretics |
|
Phase 3 |
|
|
|
8 |
|
Hormones |
|
Phase 3 |
|
|
|
9 |
|
Hormone Antagonists |
|
Phase 3 |
|
|
|
10 |
|
Diuretics, Potassium Sparing |
|
Phase 3 |
|
|
|
11 |
|
Mineralocorticoids |
|
Phase 3 |
|
|
|
12 |
|
Mineralocorticoid Receptor Antagonists |
|
Phase 3 |
|
|
|
13 |
|
Angiotensin II |
Approved, Investigational |
Phase 2 |
|
68521-88-0, 11128-99-7, 4474-91-3 |
172198 |
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
5 L Isoleucine angiotensin II
5-Isoleucine-angiotensin II
5-L-Isoleucine angiotensin II
5-L-Isoleucineangiotensin II
Ang II
ANG-(1-8)octapeptide
Angiotensin
Angiotensin 2
Angiotensin II
Angiotensin II (human)
Angiotensin II (mouse)
Angiotensin II, 5-L-isoleucine
Angiotensin-(1-8) octapeptide
Angiotonin
|
Asp-arg-val-tyr-ile-his-pro-phe
Delivert
Human angiotensin II
Hypertensin
II, 5-L-isoleucine angiotensin
Ile(5)-angiotensin II
Ile5-angiotensin II
Isoleucine(5)-angiotensin
Isoleucine(5)-angiotensin II
isoleucine5-angiotensin II
Isoleucyl(5)-angiotensin II
N-(1-(N-(N-(N-(N-(N(2)-L-a-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-alpha-Aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
N-(1-(N-(N-(N-(N-(N(2)-L-Α-aspartyl-L-arginyl)-L-valyl)-L-tyrosyl)-L-isoleucyl)-L-histidyl)-L-prolyl)-L-phenylalanine
Valyl(5)-angiotensin II
|
|
14 |
|
Amlodipine |
Approved |
Phase 2 |
|
88150-42-9 |
2162 |
Synonyms:
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid
Almirall brand OF amlodipine besilate
Amlocard
Amlodipine
Amlodipine Benzenesulfonate
Amlodipine besilate
Amlodipine besylate
amlodipine besylate|amlodipine maleate|Copalia® (amlodipine + valsartan)|Katerzia® (amlodipine oral suspension, 1 mg/mL)|Norvasc®|UK-4834011
Amlodipine free base
Amlodipine maleate
Amlodipine maleate (1:1)
Amlodipine, (+-)-isomer
Amlodipine, (+-)-isomer, maleate (1:1)
Amlodipine, (R)-isomer
Amlodipine, (S)-isomer, maleate (1:1)
Amlodipino
Amlodipino [Spanish]
Amlodipinum
|
Amlodipinum [Latin]
Amlodis
Amlor
AMVAZ
Astudal
ASTUDAL 5
CKD-330 COMPONENT AMLODIPINE
Coroval
Eczacibasi brand OF amlodipine besilate
HGP0904
HGP-0904
Istin
Lipinox
Lotrel
Mack brand OF amlodipine besilate
NORVAS
Norvasc
Pelmec
Pfizer brand OF amlodipine besilate
Racemic amlodipine
|
|
15 |
|
Valsartan |
Approved, Investigational |
Phase 2 |
|
137862-53-4 |
60846 |
Synonyms:
(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
CGP-48933
CGP-48933|Diovan®|Prexxartan® (oral solution)
Diovan
EXFORGE
Kalpress
Miten
N-(p-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
Nisis
|
N-Pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-Valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
PREXXARTAN
Provas
Tareg
VAL489
Vals
VALSARTAN
|
|
16 |
|
Hydrochlorothiazide |
Approved, Vet_approved |
Phase 2 |
|
58-93-5 |
3639 |
Synonyms:
3,4-Dihydrochlorothiazide
6-CHLORO-1,1-DIOXO-3,4-DIHYDRO-2H-1$L^{6},2,4-BENZOTHIADIAZINE-7-SULFONAMIDE
Acuretic
Aldactazide
Aldoril
APO-HYDRO
Apo-hydro®
Apresazide
Aquarills
Aquarius
Bremil
Caplaril
Capozide
Chlorosulthiadil
Chlorothiazide
Chlorsulfonamidodihydrobenzothiadiazine dioxide
Chlorzide
Cidrex
COTAREG
Dichlorosal
Dichlorotride
Dichlothiazide
Dichlotiazid
Dichlotride
Diclotride
Dicyclotride
Dihydrochlorothiazid
Dihydrochlorothiazide
Dihydrochlorothiazidum
Dihydrochlorurit
Dihydrochlorurite
Dihydroxychlorothiazidum
Direma
Disalunil
Diu-Melusin
Diuril
Drenol
Dyazide
ESI879
Esidrex
Esidrix
ESIDRIX (TN)
Esimil
Fluvin
HCT
HCTZ
HCZ
Hidril
Hidrochlortiazid
Hidroclorotiazida
Hidroronol
Hidrotiazida
Hydril
|
Hydro-aquil
Hydrochloro thiazide
Hydrochlorothiazid
HYDROCHLOROTHIAZIDE
Hydrochlorothiazide intensol
Hydrochlorothiazidum
Hydrochlorthiazide
Hydro-D
Hydrodiuretic
Hydrodiuril
Hydro-diuril
Hydropres
Hydrosaluric
Hydrothide
Hydrozide
Hypothiazid
Hypothiazide
Hyzaar
Idrotiazide
Inderide
Ivaugan
Jen-diril
Lopressor HCT
Lotensin HCT
Maschitt
Maxzide
Megadiuril
Microzide
Moduretic
Nefrix
Neo-codema
Neoflumen
Newtolide
NSC-53477
Oretic
Panurin
Prinzide
Ro-hydrazide
Sectrazide
Ser-ap-es
Servithiazid
SU-5879
Thiaretic
Thiuretic
Thlaretic
Timolide
Unipres
Urodiazin
Vaseretic
Vetidrex
Ziac
Zide
|
|
17 |
|
Antihypertensive Agents |
|
Phase 2 |
|
|
|
18 |
|
Angiotensinogen |
|
Phase 2 |
|
|
16133225 |
Synonyms:
Hypertensinogen
Proangiotensin
Renin substrate
Renin substrate tetradecapeptide
|
Renin-substrate
Serpin a8
SERPINA8
Tetradecapeptide, renin substrate
|
|
19 |
|
Angiotensin Receptor Antagonists |
|
Phase 2 |
|
|
|
20 |
|
Angiotensin II Type 1 Receptor Blockers |
|
Phase 2 |
|
|
|
21 |
|
Giapreza |
|
Phase 2 |
|
|
|
22 |
|
Sacubitril and valsartan sodium hydrate drug combination |
|
Phase 2 |
|
|
|
23 |
|
Grape |
Approved |
Phase 1 |
|
|
|
24 |
|
Quercetin |
Experimental, Investigational |
Phase 1 |
|
117-39-5 |
10283929 5320834 5280343 |
Synonyms:
(2S,3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl (2S,3S,4S,5R,6S)-6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-benzopyran-4-one
2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl b-D-glucopyranosyl-(1->6)-b-D-glucopyranoside
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl b-D-glucosyl-(1->6)-b-D-glucoside
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl beta-D-glucosyl-(1->6)-beta-D-glucoside
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl β-D-glucopyranosyl-(1->6)-β-D-glucopyranoside
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl β-D-glucosyl-(1->6)-β-D-glucoside
3,3',4,5,7-Pentahydroxyflavone
3,3',4',5,7-Pentahydroxyflavone
3,3’,4’,5,7-Pentahydroxyflavone
3,4',5,5',7-Pentahydroxy-flavone
3',4',5,7-Tetrahydroxyflavan-3-ol
3',4',5,7-Tetrahydroxyflavon-3-ol
3,5,7,3',4'-Pentahydroxyflavone
3,5,7,3’,4’-Pentahydroxyflavone
3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-ON
3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one
3’-Hydroxykaempferol
3'-Hydroxykaempferol
b-D-Glucosyl-(1->6)-b-D-glucoside
beta-D-Glucosyl-(1->6)-beta-D-glucoside
C.I. NATURAL RED 1
Dikvertin
|
Flavin meletin
LDN 0052529
LDN-0052529
Meletin
NSC 57655
NSC 9219
NSC-57655
NSC-9219
QUERCETIN
Quercetin 3-b-gentiobioside
Quercetin 3-gentiobioside
Quercetin 3-O-gentobioside
Quercetin 3-β-gentiobioside
Quercetin b-D-glucopyranosyl-(1->6)-b-D-glucopyranoside
Quercetin beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside
Quercetin dihydrate
Quercetin β-D-glucopyranosyl-(1->6)-β-D-glucopyranoside
Quercetin-3-gentiobioside
Quercetine
Quercetol
Quertin
Quertine
Sophoretin
Xanthaurine
Β-D-glucosyl-(1->6)-β-D-glucoside
|
|
25 |
|
Resveratrol |
Investigational |
Phase 1 |
|
501-36-0 |
445154 |
Synonyms:
(E)-2-(3,5-Dihydroxyphenyl)-1-(4-hydroxyphenyl)ethene
(E)-3,4',5-Trihydroxystilbene
(E)-3,4’,5-Trihydroxystilbene
(e)-5-(2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol
(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol
(E)-5-(p-Hydroxystyryl)resorcinol
(E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol
(e)-Resveratrol
3,4',5-Stilbenetriol
3,4',5-stilbenetriol|3,5,4'-trihydroxystilbene|trans-resveratrol
3,4',5-Trihydroxystilbene
3,4',5-Trihydroxy-trans-stilbene
3,4’,5-Stilbenetriol
3,4’,5-Trihydroxystilbene
3,4’,5-Trihydroxy-trans-stilbene
|
3,5,4'-Trihydroxystilbene
3,5,4'-TRIHYDROXY-TRANS-STILBENE
5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol
5-[(e)-2-(4-Hydroxyphenyl)vinyl]benzene-1,3-diol
BIA 6-512
BIA-6-512
NSC-327430
Resveratrol
SRT 501
SRT-501
trans Resveratrol
trans-3,4',5 - Trihydroxystilbene
trans-3,5,4’-Trihydroxystilbene
trans-3,5,4'-Trihydroxystilbene
trans-Resveratrol
|
|
26 |
|
Antioxidants |
|
Phase 1 |
|
|
|
27 |
|
Anthocyanidin |
|
Phase 1 |
|
|
|
28 |
|
Platelet Aggregation Inhibitors |
|
Phase 1 |
|
|
|
29 |
|
Grape Seed Extract |
|
Phase 1 |
|
|
91973920 |
Synonyms:
|
30 |
|
Protective Agents |
|
Phase 1 |
|
|
|
31 |
|
Benzocaine |
Approved, Investigational |
|
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
32 |
|
Tannic acid |
Approved |
|
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
33 |
|
Atropine |
Approved, Vet_approved |
|
|
101-31-5, 5908-99-6, 51-55-8 |
3661 154417 174174 |
Synonyms:
(-)-Atropine
(−)-ATROPINE
(-)-Hyoscyamine
(−)-HYOSCYAMINE
(±)-atropine
(±)-hyoscyamine
(Leo)-atropine
(Leo)-hyoscyamine
(S)-(-)-Hyoscyamine
(S)-(−)-HYOSCYAMINE
(S)-(Leo)-hyoscyamine
(S)Atropine
(S)-ATROPINE
[3(S)-endo]-a-(Hydroxymethyl)benzeneacetate 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-a-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-alpha-(Hydroxymethyl)benzeneacetate 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-Α-(hydroxymethyl)benzeneacetate 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-Α-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
Anaspaz
ATROJECT
ATROPEN
Atropen®|hyoscyamine
ATROPHATE
Atropin
Atropina
ATROPINE
ATROPINE (AUTOINJECTOR)
Atropine sulfate, 3(S)-endo-isomer
Atropine, 3(S)-endo-isomer
Atropinum
BUWECON
CYSTOSPAZ
Cytospaz
|
DATURIN
Daturine
dl-Hyoscyamine
dl-tropyltropate
DONNAMAR
Duboisine
EGAZIL
Hyocyamine
HYOMAX
HYOSCYAMIN
Hyoscyamine
Hyoscyamine hydrobromide
Hyoscyamine hydrochloride
Hyoscyamine sulfate
Hyoscyamine sulfate anhydrous
HYOSCYAMINUM
ISOPTO ATROPINE
L-Atropine
LEVBID
LEVSIN
LEVSINEX
L-Hyopscyamine
L-Hyoscamine
L-Hyoscyamine
L-Tropine tropate
L-Tropine tropic acid
NEOQUESS
NULEV
SPACOL T/S
SYMAX
Tropine tropate
Tropine, (-)-tropate
Tropine, (-)-tropic acid
TROPINE-L-TROPATE
|
|
34 |
|
Parasympatholytics |
|
|
|
|
|
35 |
|
Bronchodilator Agents |
|
|
|
|
|
36 |
|
Neurotransmitter Agents |
|
|
|
|
|
37 |
|
Anti-Asthmatic Agents |
|
|
|
|
|
38 |
|
Anti-Arrhythmia Agents |
|
|
|
|
|
39 |
|
Anesthetics |
|
|
|
|
|
40 |
|
Respiratory System Agents |
|
|
|
|
|
41 |
|
Mydriatics |
|
|
|
|
|
42 |
|
Muscarinic Antagonists |
|
|
|
|
|
43 |
|
Cholinergic Antagonists |
|
|
|
|
|
44 |
|
Cholinergic Agents |
|
|
|
|
|
Interventional clinical trials:
(show all 16)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan |
Unknown status |
NCT00517322 |
Phase 4 |
ramipril;irbesartan |
2 |
Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease |
Completed |
NCT00865501 |
Phase 3 |
spironolactone;placebo |
3 |
Role of ARNi in Ventricular Remodeling in Hypertensive LVH |
Recruiting |
NCT03553810 |
Phase 2 |
Entresto;Valsartan |
4 |
GRAPe Seed Extract and Ventriculovascular Investigation in Normal Ejection-Fraction Heart Failure |
Completed |
NCT01185067 |
Phase 1 |
grape seed extract (MegaNatural BP, Polyphenolics, Inc.) |
5 |
E_Stethoscope : Portable Digital Auscultation Based on Wireless Sensor Node to Diagnose Diastolic Dysfunction in Hypertensive Heart Disease |
Unknown status |
NCT02809040 |
|
|
6 |
Asian American Partnerships in Research and Empowerment (AsPIRE) |
Completed |
NCT03100812 |
|
|
7 |
EARLY Differentiation of MYOcardial Hypertrophy Between Hypertensive Heart Disease and Hypertrophic Cardiomyopathy |
Completed |
NCT03271385 |
|
|
8 |
Renal Sympathetic Denervation Restores Autonomic Imbalance and Prevents Atrial Fibrillation in Patients With Hypertensive Heart Disease: a Pilot Study |
Completed |
NCT01990911 |
|
Medical therapy |
9 |
Effects of the Dietary Approaches to Stop Hypertension(DASH) Sodium-restricted Diet on Ventriculovascular Function in Heart Failure With Preserved Systolic Function |
Completed |
NCT00939640 |
|
|
10 |
The Personalized Chinese Herb Formulas Are Evaluated for Their Effectiveness to Relieve Symptoms in Hypertensive Bradyarrhythmia |
Completed |
NCT04505228 |
|
Safflower (Carthamus Tinctorius) IgG4 | Serum | Allergy;Atropine Sulfate |
11 |
Association Between Enhanced Sympathetic Activity and Cardiometabolic Complications: a Cross-sectional Study on Predictive Power of 24-hour Urinary Metanephrines (SYMPACT) |
Completed |
NCT04495231 |
|
|
12 |
Prevention of Cardiovascular Stiffening With Aging and Hypertensive Heart Disease |
Completed |
NCT03476785 |
|
|
13 |
Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline |
Recruiting |
NCT04682977 |
|
|
14 |
Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection (ACTIV4) |
Recruiting |
NCT05226416 |
|
|
15 |
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study |
Enrolling by invitation |
NCT04190420 |
|
|
16 |
Dietary Approaches to Stop Hypertension in 'Diastolic' Heart Failure 2 (DASH-DHF 2) |
Terminated |
NCT01942395 |
|
|
|